他汀类药物使用与头颈癌呈负相关:汉族人群的基于人群的病例对照研究
该病例对照研究利用台湾纵向健康保险数据库的理赔数据,纳入5515例头颈癌患者和5515例倾向评分匹配的无头颈癌对照,分析既往他汀暴露与头颈癌发生的关系。结果显示,病例组他汀暴露比例为15.99%,对照组为17.91%,校正优势比为0.86(95%CI:0.77-0.95)。结论认为他汀使用与头颈癌发生呈负相关。
要点
- 在汉族人群中,既往他汀暴露与头颈癌发生呈负相关,校正OR为0.86(95%CI:0.77-0.95)。
- 病例组他汀暴露比例为15.99%,低于对照组的17.91%。
- 研究基于台湾纵向健康保险数据库的理赔数据,采用倾向评分匹配的病例对照设计。
核心结论
- 他汀使用与头颈癌发生呈负相关。
研究设计与样本
- 基于台湾纵向健康保险数据库理赔数据的病例对照研究,纳入5515例头颈癌患者和5515例倾向评分匹配的无头颈癌对照,共11030例。
主要发现
- 全部11030例样本中,16.95%曾有他汀处方记录。
- 病例组他汀暴露比例为15.99%,对照组为17.91%。
- 条件logistic回归显示,病例组既往他汀暴露的校正优势比为0.86(95%CI:0.77-0.95),对照为倾向评分匹配的无头颈癌患者。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This case-control study aimed to find the relationship between prior statin use and head and neck cancer occurrence using a large population-based database. METHODS: This study used claims data from the Taiwan Longitudinal Health Insurance Database. We included 5515 patients with head and neck cancer as cases and 5515 propensity score-matched patients without head and neck cancer as controls. Conditional logistic regressions were performed to investigate the relationship between head and neck cancer and prior statin exposure. RESULTS: Of the 11 030 total sampled patients, 16.95% had previously received prescriptions for statins. In addition, statin exposure was found in 15.99% of cases and 17.91% of controls. The logistic regression also revealed that the adjusted odds ratio of prior statin exposure for cases was 0.86 (95% confidence interval: 0.77-0.95) compared to propensity score-matched controls. CONCLUSION: This study found an inverse association between statin usage and head and neck cancer occurrence.
引用
- Kao LT, Hung SH, Kao PF, et al. Inverse association between statin use and head and neck cancer: Population-based case-control study in Han population. Head Neck. 2019. PMID: 30809863. doi:10.1002/hed.25501
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。